Eosinophil-associated lung diseases: A cry for surfactant proteins A and D help?

American Journal of Respiratory Cell and Molecular Biology

Volumn 51, Issue 5, 2014, Pages 604-614

  Ledford, Julie G ^a   Addison, Kenneth J ^a   Foster, Matthew W ^a   Que, Loretta G ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Collectin; Eosinophil; Surfactant; Surfactant protein A; Surfactant protein D

Indexed keywords

SFTPA1 PROTEIN, HUMAN; SFTPA2 PROTEIN, HUMAN; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D;

BLOOD; EOSINOPHIL; HUMAN; IMMUNOLOGY; LUNG DISEASE; METABOLISM;

EOSINOPHILS; HUMANS; LUNG DISEASES; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D;

EID: 84914117749     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2014-0095TR     Document Type: Review

References (144)

1. Hakansson K, Lim NK, Hoppe HJ, Reid KB. Crystal structure of the trimeric alpha-helical coiled-coil and the three lectin domains of human lung surfactant protein D. Structure 1999;7:255-264.
2. Crouch E, Persson A, Chang D, Heuser J. Molecular structure of pulmonary surfactant protein D (SP-D). J Biol Chem 1994;269: 17311-17319.
3. Wright JR. Immunoregulatory functions of surfactant proteins. Nat Rev Immunol 2005;5:58-68.
4. Winkler C, Hohlfeld JM. Surfactant and allergic airway inflammation. Swiss Med Wkly 2013;143:w13818.
5. LeVine AM, Elliott J, Whitsett JA, Srikiatkhachorn A, Crouch E, DeSilva N, Korfhagen T. Surfactant protein-d enhances phagocytosis and pulmonary clearance of respiratory syncytial virus. Am J Respir Cell Mol Biol 2004;31:193-199.
6. Ofek I, Mesika A, Kalina M, Keisari Y, Podschun R, Sahly H, Chang D, McGregor D, Crouch E. Surfactant protein D enhances phagocytosis and killing of unencapsulated phase variants of Klebsiella pneumoniae. Infect Immun 2001;69:24-33.
7. Restrepo CI, Dong Q, Savov J, Mariencheck WI, Wright JR. Surfactant protein D stimulates phagocytosis of Pseudomonas aeruginosa by alveolar macrophages. Am J Respir Cell Mol Biol 1999;21:576-585.
8. Schagat TL, Tino MJ, Wright JR. Regulation of protein phosphorylation and pathogen phagocytosis by surfactant protein A. Infect Immun 1999;67:4693-4699.
9. LeVine AM, Kurak KE, Wright JR, Watford WT, Bruno MD, Ross GF, Whitsett JA, Korfhagen TR. Surfactant protein-A binds group B streptococcus enhancing phagocytosis and clearance from lungs of surfactant protein-A-deficient mice. Am J Respir Cell Mol Biol 1999;20:279-286.
10. Tino MJ, Wright JR. Surfactant protein A stimulates phagocytosis of specific pulmonary pathogens by alveolar macrophages. Am J Physiol 1996;270:L677-L688.
11. Geertsma MF, Nibbering PH, Haagsman HP, Daha MR, van Furth R. Binding of surfactant protein A to C1q receptors mediates phagocytosis of Staphylococcus aureus by monocytes. Am J Physiol 1994;267:L578-L584.
12. Sakai K, Kweon MN, Kohri T, Kishino Y. Effects of pulmonary surfactant and surfactant protein A on phagocytosis of fractionated alveolar macrophages: relationship to starvation. Cell Mol Biol 1992;38:123-130.
13. Manz-Keinke H, Plattner H, Schlepper-Schafer J. Lung surfactant protein A (SP-A) enhances serum-independent phagocytosis of bacteria by alveolar macrophages. Eur J Cell Biol 1992;57: 95-100.
14. van Iwaarden JF, van Strijp JA, Ebskamp MJ, Welmers AC, Verhoef J, van Golde LM. Surfactant protein A is opsonin in phagocytosis of herpes simplex virus type 1 by rat alveolar macrophages. Am J Physiol 1991;261:L204-L209.
15. Tenner AJ, Robinson SL, Borchelt J, Wright JR. Human pulmonary surfactant protein (SP-A), a protein structurally homologous to C1q, can enhance FcR-and CR1-mediated phagocytosis. J Biol Chem 1989;264:13923-13928.
16. Geunes-Boyer S, Oliver TN, Janbon G, Lodge JK, Heitman J, Perfect JR, Wright JR. Surfactant protein D increases phagocytosis of hypocapsular Cryptococcus neoformans by murine macrophages and enhances fungal survival. Infect Immun 2009;77:2783-2794.
17. Gaynor CD, McCormack FX, Voelker DR, McGowan SE, Schlesinger LS. Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages. J Immunol 1995; 155:5343-5351.
18. Koziel H, Phelps DS, Fishman JA, Armstrong MY, Richards FF, Rose RM. Surfactant protein-A reduces binding and phagocytosis of pneumocystis carinii by human alveolar macrophages in vitro. Am J Respir Cell Mol Biol 1998;18:834-843.
19. Yong SJ, Vuk-Pavlovic Z, Standing JE, Crouch EC, Limper AH. Surfactant protein D-mediated aggregation of Pneumocystis carinii impairs phagocytosis by alveolar macrophages. Infect Immun 2003;71:1662-1671.
20. Holmer SM, Evans KS, Asfaw YG, Saini D, Schell WA, Ledford JG, Frothingham R, Wright JR, Sempowski GD, Perfect JR. Impact of surfactant protein D, interleukin-5, and eosinophilia on Cryptococcosis. Infect Immun 2014;82:683-693.
21. Jambo KC, French N, Zijlstra E, Gordon SB. AIDS patients have increased surfactant protein D but normal mannose binding lectin levels in lung fluid. Respir Res 2007;8:42.
22. Paganelli R, Scala E, Mazzone AM, Rosso R, Mattiacci G, Dell'Anna L, Mezzaroma I, Aiuti F. Th2-type cytokines, hypereosinophilia, and interleukin-5 in HIV disease. Allergy 1997;52:110-111.
23. Wofford JA, Wright JR. Surfactant protein A regulates IgG-mediated phagocytosis in inflammatory neutrophils. Am J Physiol Lung Cell Mol Physiol 2007;293:L1437-L1443.
24. Watford WT, Smithers MB, Frank MM, Wright JR. Surfactant protein A enhances the phagocytosis of C1q-coated particles by alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 2002;283:L1011-L1022.
25. Schagat TL, Wofford JA, Wright JR. Surfactant protein A enhances alveolar macrophage phagocytosis of apoptotic neutrophils. J Immunol 2001;166:2727-2733.
26. Reidy MF, Wright JR. Surfactant protein A enhances apoptotic cell uptake and TGF-beta1 release by inflammatory alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 2003;285:L854-L861.
27. Erpenbeck VJ, Malherbe DC, Sommer S, Schmiedl A, Steinhilber W, Ghio AJ, Krug N, Wright JR, Hohlfeld JM. Surfactant protein D increases phagocytosis and aggregation of pollen-allergen starch granules. Am J Physiol Lung Cell Mol Physiol 2005;288: L692-L698.
28. Winkler C, Huper K, Wedekind AC, Rochlitzer S, Hartwig C, Muller M, Braun A, Krug N, Hohlfeld JM, Erpenbeck VJ. Surfactant protein D modulates pulmonary clearance of pollen starch granules. Exp Lung Res 2010;36:522-530.
29. Palaniyar N, Clark H, Nadesalingam J, Hawgood S, Reid KB. Surfactant protein D binds genomic DNA and apoptotic cells, and enhances their clearance, in vivo. Ann N Y Acad Sci 2003; 1010:471-475.
30. Kendall M, Ding P, Mackay RM, Deb R, McKenzie Z, Kendall K, Madsen J, Clark H. Surfactant protein D (SP-D) alters cellular uptake of particles and nanoparticles. Nanotoxicology 2013;7: 963-973.
31. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A. Neutrophil extracellular traps kill bacteria. Science 2004;303:1532-1535.
32. Cheng OZ, Palaniyar N. NET balancing: a problem in inflammatory lung diseases. Front Immunol 2013;4:1.
33. Douda DN, Jackson R, Grasemann H, Palaniyar N. Innate immune collectin surfactant protein D simultaneously binds both neutrophil extracellular traps and carbohydrate ligands and promotes bacterial trapping. J Immunol 2011;187:1856-1865.
34. Yousefi S, Gold JA, Andina N, Lee JJ, Kelly AM, Kozlowski E, Schmid I, Straumann A, Reichenbach J, Gleich GJ, et al. Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense. Nat Med 2008;14:949-953.
35. Yousefi S, Simon D, Simon HU. Eosinophil extracellular DNA traps: molecular mechanisms and potential roles in disease. Curr Opin Immunol 2012;24:736-739.
36. Gardai SJ, Xiao YQ, Dickinson M, Nick JA, Voelker DR, Greene KE, Henson PM. By binding SIRPalpha or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell 2003;115:13-23.
37. Nguyen HA, Rajaram MV, Meyer DA, Schlesinger LS. Pulmonary surfactant protein A and surfactant lipids upregulate IRAK-M, a negative regulator of TLR-mediated inflammation in human macrophages. Am J Physiol Lung Cell Mol Physiol 2012;303: L608-L616.
38. Sender V, Lang L, Stamme C. Surfactant protein-A modulates LPS-induced TLR4 localization and signaling via beta-arrestin 2. PLoS ONE 2013;8:e59896.
39. Atochina-Vasserman EN. S-nitrosylation of surfactant protein D as a modulator of pulmonary inflammation. Biochim Biophys Acta 2012;1820:763-769.
40. Fisher AB, Dodia C, Ruckert P, Tao JQ, Bates SR. Pathway to lamellar bodies for surfactant protein A. Am J Physiol Lung Cell Mol Physiol 2010;299:L51-L58.
41. Williams MC, Hawgood S, Hamilton RL. Changes in lipid structure produced by surfactant proteins SP-A, SP-B, and SP-C. Am J Respir Cell Mol Biol 1991;5:41-50.
42. Poulain FR, Allen L, Williams MC, Hamilton RL, Hawgood S. Effects of surfactant apolipoproteins on liposome structure: implications for tubular myelin formation. Am J Physiol 1992;262:L730-L739.
43. Froh D, Ballard PL, Williams MC, Gonzales J, Goerke J, Odom MW, Gonzales LW. Lamellar bodies of cultured human fetal lung: content of surfactant protein A (SP-A), surface film formation and structural transformation in vitro. Biochim Biophys Acta 1990;1052:78-89.
44. Madsen J, Tornoe I, Nielsen O, Koch C, Steinhilber W, Holmskov U. Expression and localization of lung surfactant protein A in human tissues. Am J Respir Cell Mol Biol 2003;29:591-597.
45. Wong CJ, Akiyama J, Allen L, Hawgood S. Localization and developmental expression of surfactant proteins D and A in the respiratory tract of the mouse. Pediatr Res 1996;39:930-937.
46. Crouch EC. Collectins and pulmonary host defense. Am J Respir Cell Mol Biol 1998;19:177-201.
47. Crouch E, Parghi D, Kuan SF, Persson A. Surfactant protein D: subcellular localization in nonciliated bronchiolar epithelial cells. Am J Physiol 1992;263:L60-L66.
48. Voorhout WF, Veenendaal T, Kuroki Y, Ogasawara Y, van Golde LM, Geuze HJ. Immunocytochemical localization of surfactant protein D (SP-D) in type II cells, Clara cells, and alveolar macrophages of rat lung. J Histochem Cytochem 1992;40: 1589-1597.
49. Chander A, Reicherter J, Fisher AB. Degradation of dipalmitoyl phosphatidylcholine by isolated rat granular pneumocytes and reutilization for surfactant synthesis. J Clin Invest 1987;79: 1133-1138.
50. Fisher AB, Chander A, Reicherter J. Uptake and degradation of natural surfactant by isolated rat granular pneumocytes. Am J Physiol 1987;253:C792-C796.
51. Fisher AB, Dodia C, Chander A. Alveolar uptake of lipid and protein components of surfactant. Am J Physiol 1991;261: L334-L340.
52. Bates SR, Fisher AB. Surfactant protein A is degraded by alveolar macrophages. Am J Physiol 1996;271:L258-L266.
53. Gurel O, Ikegami M, Chroneos ZC, Jobe AH. Macrophage and type II cell catabolism of SP-A and saturated phosphatidylcholine in mouse lungs. Am J Physiol Lung Cell Mol Physiol 2001; 280:L1266-L1272.
54. Wright JR. Clearance and recycling of pulmonary surfactant. Am J Physiol 1990;259:L1-L12.
55. Baritussio A, Alberti A, Armanini D, Meloni F, Bruttomesso D. Different pathways of degradation of SP-A and saturated phosphatidylcholine by alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 2000;279:L91-L99.
56. Jain D, Dodia C, Fisher AB, Bates SR. Pathways for clearance of surfactant protein A from the lung. Am J Physiol Lung Cell Mol Physiol 2005;289:L1011-L1018.
57. Griese M. Pulmonary surfactant in health and human lung diseases: state of the art. Eur Respir J 1999;13:1455-1476.
58. Wang JY, Shieh CC, Yu CK, Lei HY. Allergen-induced bronchial inflammation is associated with decreased levels of surfactant proteins A and D in a murine model of asthma. Clin Exp Allergy 2001;31:652-662.
59. Haley KJ, Ciota A, Contreras JP, Boothby MR, Perkins DL, Finn PW. Alterations in lung collectins in an adaptive allergic immune response. Am J Physiol Lung Cell Mol Physiol 2002; 282:L573-L584.
60. Kasper M, Sims G, Koslowski R, Kuss H, Thuemmler M, Fehrenbach H, Auten RL. Increased surfactant protein D in rat airway goblet and Clara cells during ovalbumin-induced allergic airway inflammation. Clin Exp Allergy 2002;32: 1251-1258.
61. Ledford JG, Mukherjee S, Kislan MM, Nugent JL, Hollingsworth JW, Wright JR. Surfactant protein-A suppresses eosinophilmediated killing of Mycoplasma pneumoniae in allergic lungs. PLoS ONE 2012;7:e32436.
62. von Bredow C, Hartl D, Schmid K, Schabaz F, Brack E, Reinhardt D, Griese M. Surfactant protein D regulates chemotaxis and degranulation of human eosinophils. Clin Exp Allergy 2006;36: 1566-1574.
63. Cheng G, Ueda T, Nakajima H, Nakajima A, Arima M, Kinjyo S, Fukuda T. Surfactant protein A exhibits inhibitory effect on eosinophils IL-8 production. Biochem Biophys Res Commun 2000;270:831-835.
64. Pastva AM, Mukherjee S, Giamberardino C, Hsia B, Lo B, Sempowski GD, Wright JR. Lung effector memory and activated CD41 T cells display enhanced proliferation in surfactant protein A-deficient mice during allergen-mediated inflammation. J Immunol 2011;186:2842-2849.
65. Madan T, Reid KB, Singh M, Sarma PU, Kishore U. Susceptibility of mice genetically deficient in the surfactant protein (SP)-A or SP-D gene to pulmonary hypersensitivity induced by antigens and allergens of Aspergillus fumigatus. J Immunol 2005;174: 6943-6954.
66. Jarjour NN, Enhorning G. Antigen-induced airway inflammation in atopic subjects generates dysfunction of pulmonary surfactant. Am J Respir Crit Care Med 1999;160:336-341.
67. Hohlfeld JM, Ahlf K, Enhorning G, Balke K, Erpenbeck VJ, Petschallies J, Hoymann HG, Fabel H, Krug N. Dysfunction of pulmonary surfactant in asthmatics after segmental allergen challenge. Am J Respir Crit Care Med 1999;159:1803-1809.
68. Schmiedl A, Krug N, Hohlfeld JM. Influence of plasma and inflammatory proteins on the ultrastructure of exogenous surfactant. J Electron Microsc (Tokyo) 2004;53:407-416.
69. Wang Y, Voelker DR, Lugogo NL, Wang G, Floros J, Ingram JL, Chu HW, Church TD, Kandasamy P, Fertel D, et al. Surfactant protein A is defective in abrogating inflammation in asthma. Am J Physiol Lung Cell Mol Physiol 2011;301:L598-L606.
70. Shorr AF, Scoville SL, Cersovsky SB, Shanks GD, Ockenhouse CF, Smoak BL, Carr WW, Petruccelli BP. Acute eosinophilic pneumonia among US military personnel deployed in or near Iraq. JAMA 2004;292:2997-3005.
71. Allen JN, Liao Z, Wewers MD, Altenberger EA, Moore SA, Allen ED. Detection of IL-5 and IL-1 receptor antagonist in bronchoalveolar lavage fluid in acute eosinophilic pneumonia. J Allergy Clin Immunol 1996;97:1366-1374.
72. Daimon T, Tajima S, Oshikawa K, Bando M, Ohno S, Sugiyama Y. KL-6 and surfactant proteins A and D in serum and bronchoalveolar lavage fluid in patients with acute eosinophilic pneumonia. Intern Med 2005;44:811-817.
73. Wright JR. Immunomodulatory functions of surfactant. Physiol Rev 1997;77:931-962.
74. Reid KB. Interactions of surfactant protein D with pathogens, allergens and phagocytes. Biochim Biophys Acta 1998;1408: 290-295.
75. Madan T, Kishore U, Singh M, Strong P, Clark H, Hussain EM, Reid KB, Sarma PU. Surfactant proteins A and D protect mice against pulmonary hypersensitivity induced by Aspergillus fumigatus antigens and allergens. J Clin Invest 2001;107: 467-475.
76. Haczku A, Atochina EN, Tomer Y, Chen H, Scanlon ST, Russo S, Xu J, Panettieri RA Jr, Beers MF. Aspergillus fumigatus-induced allergic airway inflammation alters surfactant homeostasis and lung function in BALB/c mice. Am J Respir Cell Mol Biol 2001;25:45-50.
77. Krane M, Griese M. Surfactant protein D in serum from patients with allergic bronchopulmonary aspergillosis. Eur Respir J 2003;22:592-595.
78. Kishore U, Kojouharova MS, Reid KB. Recent progress in the understanding of the structure-function relationships of the globular head regions of C1q. Immunobiology 2002;205: 355-364.
79. Saxena S, Madan T, Shah A, Muralidhar K, Sarma PU. Association of polymorphisms in the collagen region of SP-A2 with increased levels of total IgE antibodies and eosinophilia in patients with allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2003;111:1001-1007.
80. Madan T, Kaur S, Saxena S, Singh M, Kishore U, Thiel S, Reid KB, Sarma PU. Role of collectins in innate immunity against aspergillosis. Med Mycol 2005;43:S155-S163.
81. Strong P, Reid KB, Clark H. Intranasal delivery of a truncated recombinant human SP-D is effective at down-regulating allergic hypersensitivity in mice sensitized to allergens of Aspergillus fumigatus. Clin Exp Immunol 2002;130:19-24.
82. Broide DH. Allergic rhinitis: pathophysiology. Allergy Asthma Proc 2010;31:370-374.
83. Ren J, Deng Y, Xiao B, Wang G, Tao Z. Protective effects of exogenous surfactant protein A in allergic rhinitis: a mouse model. Ann Otol Rhinol Laryngol 2013;122:240-246.
84. Schicht M, Knipping S, Hirt R, Beileke S, Sel S, Paulsen F, Brauer L. Detection of surfactant proteins A, B, C, and D in human nasal mucosa and their regulation in chronic rhinosinusitis with polyps. Am J Rhinol Allergy 2013;27:24-29.
85. Deng Y, Zuo J, Tao Z, Kong Y, Xiao B. Expression and significance of SP-A in nasal mucosa of allergic rhinitis and nasal polyp (In Chinese]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2009;23:642-645.
86. Wootten CT, Labadie RF, Chen A, Lane KF. Differential expression of surfactant protein A in the nasal mucosa of patients with allergy symptoms. Arch Otolaryngol Head Neck Surg 2006;132:1001-1007.
87. Bohm M, Avgitidou G, El Hassan E, Mosges R. Liposomes: a new non-pharmacological therapy concept for seasonal-allergicrhinoconjunctiviti. Eur Arch Otorhinolaryngol 2012;269: 495-502.
88. Woodworth BA, Wood R, Baatz JE, Schlosser RJ. Sinonasal surfactant protein A1, A2, and D gene expression in cystic fibrosis: a preliminary report. Head Neck Surg 2007;137:34-38.
89. Woodworth BA, Wood R, Bhargave G, Cohen NA, Baatz JE, Schlosser RJ. Surfactant protein B detection and gene expression in chronic rhinosinusitis. Laryngoscope 2007;117:1296-1301.
90. Allen JN, Davis WB, Pacht ER. Diagnostic significance of increased bronchoalveolar lavage fluid eosinophils. Am Rev Respir Dis 1990;142:642-647.
91. Hamm H, Luhrs J, Guzman y Rotaeche J, Costabel U, Fabel H, Bartsch W. Elevated surfactant protein A in bronchoalveolar lavage fluids from sarcoidosis and hypersensitivity pneumonitis patients. Chest 1994;106:1766-1770.
92. Sterclova M, Vasakova M, Paluch P, Paulik M. Surfactant protein A in chronic extrinsic allergic alveolitis. Eur Respir J 2012;39: 1543-1544.
93. Gunther A, Schmidt R, Nix F, Yabut-Perez M, Guth C, Rosseau S, Siebert C, Grimminger F, Morr H, Velcovsky HG, et al. Surfactant abnormalities in idiopathic pulmonary fibrosis, hypersensitivity pneumonitis and sarcoidosis. Eur Respir J 1999;14:565-573.
94. Okamoto T, Miyazaki Y, Shirahama R, Tamaoka M, Inase N. Proteome analysis of bronchoalveolar lavage fluid in chronic hypersensitivity pneumonitis. Allergol Int 2012;61:83-92.
95. Scott KA, Wardlaw AJ. Eosinophilic airway disorders. Semin Respir Crit Care Med 2006;27:128-133.
96. Soter S, Barta I, Antus B. Predicting sputum eosinophilia in exacerbations of COPD using exhaled nitric oxide. Inflammation 2013;36:1178-1185.
97. Lusuardi M, Capelli A, Carli S, Tacconi MT, Salmona M, Donner CF. Role of surfactant in chronic obstructive pulmonary disease: therapeutic implications. Respiration 1992;59:28-32.
98. Scott JE. The pulmonary surfactant: impact of tobacco smoke and related compounds on surfactant and lung development. Tob Induc Dis 2004;2:3-25.
99. Heinrich SM, Griese M. Assessment of surfactant protein A (SP-A) dependent agglutination. BMC Pulm Med 2010;10:59.
100. Honda Y, Takahashi H, Kuroki Y, Akino T, Abe S. Decreased contents of surfactant proteins A and D in BAL fluids of healthy smokers. Chest 1996;109:1006-1009.
101. Ishikawa N, Hattori N, Tanaka S, Horimasu Y, Haruta Y, Yokoyama A, Kohno N, Kinnula VL. Levels of surfactant proteins A and D and KL-6 are elevated in the induced sputum of chronic obstructive pulmonary disease patients: a sequential sputum analysis. Respiration 2011;82:10-18.
102. Ju CR, Liu W, Chen RC. Serum surfactant protein D: biomarker of chronic obstructive pulmonary disease. Dis Markers 2012; 32:281-287.
103. Shakoori TA, Sin DD, Ghafoor F, Bashir S, Bokhari SN. Serum surfactant protein D during acute exacerbations of chronic obstructive pulmonary disease. Dis Markers 2009;27:287-294.
104. Kim DK, Cho MH, Hersh CP, Lomas DA, Miller BE, Kong X, Bakke P, Gulsvik A, Agusti A, Wouters E. Genome-wide association analysis of blood biomarkers in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012;186:1238-1247.
105. Winkler C, Atochina-Vasserman EN, Holz O, Beers MF, Erpenbeck VJ, Krug N, Roepcke S, Lauer G, Elmlinger M, Hohlfeld JM. Comprehensive characterisation of pulmonary and serum surfactant protein D in COPD. Respir Res 2011;12:29.
106. Domagala-Kulawik J, Maskey-Warzechowska M, Kraszewska I, Chazan R. The cellular composition and macrophage phenotype in induced sputum in smokers and ex-smokers with COPD. Chest 2003;123:1054-1059.
107. Deb R, Shakib F, Reid K, Clark H. Major house dust mite allergens Dermatophagoides pteronyssinus 1 and Dermatophagoides farinae 1 degrade and inactivate lung surfactant proteins A and D. J Biol Chem 2007;282:36808-36819.
108. Mariencheck WI, Alcorn JF, Palmer SM, Wright JR. Pseudomonas aeruginosa elastase degrades surfactant proteins A and D. Am J Respir Cell Mol Biol 2003;28:528-537.
109. Liau DF, Yin NX, Huang J, Ryan SF. Effects of human polymorphonuclear leukocyte elastase upon surfactant proteins in vitro. Biochim Biophys Acta 1996;1302:117-128.
110. Lecaille F, Naudin C, Sage J, Joulin-Giet A, Courty A, Andrault PM, Veldhuizen RA, Possmayer F, Lalmanach G. Specific cleavage of the lung surfactant protein A by human cathepsin S may impair its antibacterial properties. Int J Biochem Cell Biol 2013;45:1701-1709.
111. Bratcher PE, Weathington NM, Nick HJ, Jackson PL, Snelgrove RJ, Gaggar A. MMP-9 cleaves SP-D and abrogates its innate immune functions in vitro. PLoS ONE 2012;7:e41881.
112. Hirche TO, Crouch EC, Espinola M, Brokelman TJ, Mecham RP, DeSilva N, Cooley J, Remold-O'Donnell E, Belaaouaj A.Neutrophil serine proteinases inactivate surfactant protein D by cleaving within a conserved subregion of the carbohydrate recognition domain. J Biol Chem 2004;279:27688-27698.
113. Atochina-Vasserman EN, Beers MF, Gow AJ. Review: chemical and structural modifications of pulmonary collectins and their functional consequences. Innate Immun. 2010;16:175-182.
114. Yamamoto M, Tochino Y, Chibana K, Trudeau JB, Holguin F, Wenzel SE. Nitric oxide and related enzymes in asthma: relation to severity, enzyme function and inflammation. Clin Exp Allergy 2012;42:760-768.
115. Guo CJ, Atochina-Vasserman EN, Abramova E, Foley JP, Zaman A, Crouch E, Beers MF, Savani RC, Gow AJ. S-nitrosylation of surfactant protein-D controls inflammatory function. PLoS Biol 2008;6:e266.
116. Greis KD, Zhu S, Matalon S. Identification of nitration sites on surfactant protein A by tandem electrospray mass spectrometry. Arch Biochem Biophys 1996;335:396-402.
117. Zhu S, Haddad IY, Matalon S. Nitration of surfactant protein A (SP-A) tyrosine residues results in decreased mannose binding ability. Arch Biochem Biophys 1996;333:282-290.
118. Haddad IY, Zhu S, Ischiropoulos H, Matalon S. Nitration of surfactant protein A results in decreased ability to aggregate lipids. Am J Physiol 1996;270:L281-L288.
119. Matalon S, Shrestha K, Kirk M, Waldheuser S, McDonald B, Smith K, Gao Z, Belaaouaj A, Crouch EC. Modification of surfactant protein D by reactive oxygen-nitrogen intermediates is accompanied by loss of aggregating activity, in vitro and in vivo. FASEB J 2009;23:1415-1430.
120. Zhu S, Ware LB, Geiser T, Matthay MA, Matalon S. Increased levels of nitrate and surfactant protein a nitration in the pulmonary edema fluid of patients with acute lung injury. Am J Respir Crit Care Med 2001;163:166-172.
121. Zhu S, Kachel DL, Martin WJ II, Matalon S. Nitrated SP-A does not enhance adherence of Pneumocystis carinii to alveolar macrophages. Am J Physiol 1998;275:L1031-L1039.
122. Ghosh S, Erzurum SC. Nitric oxide metabolism in asthma pathophysiology. Biochim Biophys Acta 2011;1810:1008-1016.
123. MacPherson JC, Comhair SA, Erzurum SC, Klein DF, Lipscomb MF, Kavuru MS, Samoszuk MK, Hazen SL. Eosinophils are a major source of nitric oxide-derived oxidants in severe asthma: characterization of pathways available to eosinophils for generating reactive nitrogen species. J Immunol 2001;166:5763-5772.
124. Iijima H, Duguet A, Eum SY, Hamid Q, Eidelman DH. Nitric oxide and protein nitration are eosinophil dependent in allergen-challenged mice. Am J Respir Crit Care Med 2001;163:1233-1240.
125. Duguet A, Iijima H, Eum SY, Hamid Q, Eidelman DH. Eosinophil peroxidase mediates protein nitration in allergic airway inflammation in mice. Am J Respir Crit Care Med 2001;164:1119-1126.
126. Atochina-Vasserman EN, Winkler C, Abramova H, Schaumann F, Krug N, Gow AJ, Beers MF, Hohlfeld JM. Segmental allergen challenge alters multimeric structure and function of surfactant protein D in humans. Am J Respir Crit Care Med 2011;183:856-864.
127. Hohlfeld JM, Schmiedl A, Erpenbeck VJ, Venge P, Krug N. Eosinophil cationic protein alters pulmonary surfactant structure and function in asthma. J Allergy Clin Immunol 2004; 113:496-502.
128. Bernhard W, Mottaghian J, Gebert A, Rau GA, von Der HH, Poets CF. Commercial versus native surfactants: surface activity, molecular components, and the effect of calcium. Am J Respir Crit Care Med 2000;162:1524-1533.
129. Ueda T, Ikegami M, Jobe A. Surfactant subtypes: in vitro conversion, in vivo function, and effects of serum proteins. Am J Respir Crit Care Med 1994;149:1254-1259.
130. Madan T, Kishore U, Singh M, Strong P, Hussain EM, Reid KB, Sarma PU. Protective role of lung surfactant protein D in a murine model of invasive pulmonary aspergillosis. Infect Immun 2001;69:2728-2731.
131. Lin KW, Jen KY, Suarez CJ, Crouch EC, Perkins DL, Finn PW. Surfactant protein D-mediated decrease of allergen-induced inflammation is dependent upon CTLA4. J Immunol 2010;184: 6343-6349.
132. Erpenbeck VJ, Ziegert M, Cavalet-Blanco D, Martin C, Baelder R, Glaab T, Braun A, Steinhilber W, Luettig B, Uhlig S, et al. Surfactant protein D inhibits early airway response in Aspergillus fumigatus-sensitized mice. Clin Exp Allergy 2006; 36:930-940.
133. Atochina EN, Beers MF, Tomer Y, Scanlon ST, Russo SJ, Panettieri RA Jr, Haczku A. Attenuated allergic airway hyperresponsiveness in C57BL/6 mice is associated with enhanced surfactant protein (SP)-D production following allergic sensitization. Respir Res 2003;4:15.
134. Goto H, Ledford JG, Mukherjee S, Noble PW, Williams KL, Wright JR. The role of surfactant protein A in bleomycininduced acute lung injury. Am J Respir Crit Care Med 2010; 181:1336-1344.
135. Mukherjee S, Giamberardino C, Thomas JM, Gowdy K, Pastva AM, Wright JR. Surfactant protein A modulates induction of regulatory T cells via TGF-beta. J Immunol 2012;188: 4376-4384.
136. Mukherjee S, Giamberardino C, Thomas J, Evans K, Goto H, Ledford JG, Hsia B, Pastva AM, Wright JR. Surfactant protein A integrates activation signal strength to differentially modulate T cell proliferation. J Immunol 2012;188:957-967.
137. Borron P, McIntosh JC, Korfhagen TR, Whitsett JA, Taylor J, Wright JR. Surfactant-associated protein A inhibits LPS-induced cytokine and nitric oxide production in vivo. Am J Physiol Lung Cell Mol Physiol 2000;278:L840-L847.
138. Ramani V, Madhusoodhanan R, Kosanke S, Awasthi S. A TLR4-interacting SPA4 peptide inhibits LPS-induced lung inflammation. Innate Immun 2013;19:596-610.
139. Cheng G, Ueda T, Numao T, Kuroki Y, Nakajima H, Fukushima Y, Motojima S, Fukuda T. Increased levels of surfactant protein A and D in bronchoalveolar lavage fluids in patients with bronchial asthma. Eur Respir J 2000;16:831-835.
140. Erpenbeck VJ, Fischer I, Wiese K, Schaumann F, Schmiedl A, Nassenstein C, Krug N, Hohlfeld JM. Therapeutic surfactants modulate the viability of eosinophils and induce inflammatory mediator release. Int Arch Allergy Immunol 2009;149: 333-342.
141. Ghafouri B, Persson HL, Tagesson C. Intriguing bronchoalveolar lavage proteome in a case of pulmonary langerhans cell histiocytosis. Am J Case Rep 2013;14:129-133.
142. Honda Y, Takahashi H, Shijubo N, Kuroki Y, Akino T. Surfactant protein-A concentration in bronchoalveolar lavage fluids of patients with pulmonary alveolar proteinosis. Chest 1993;103: 496-499.
143. Honda Y, Kuroki Y, Matsuura E, Nagae H, Takahashi H, Akino T, Abe S. Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids. Am J Respir Crit Care Med 1995;152:1860-1866.
144. Gregory TJ, Longmore WJ, Moxley MA, Whitsett JA, Reed CR, Fowler AA III, Hudson LD, Maunder RJ, Crim C, Hyers TM. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 1991;88: 1976-1981.